sec filing
AL
NASDAQ · ALBT
Avalon GloboCare Corp.
Real Estate · Real Estate - Services
$0.28
Down-$0.01 (-4.25%)
Updated Sep 16, 2026, 7:50 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.71M
- P/E ratio
- -0.32
- Dividend yield
- 0.00%
- 52-week range
- $0.21 – $4.74
- Volume
- 9.4M
- Avg. volume
- 6.35M
Price performance
ALBT price history
1M range · 0 trading sessions · Daily adjusted prices
ALBT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ALBT news
The latest Smart Investors Daily articles mentioning ALBT.
Stock researchCompany · Overview
ALBT research
Overview
Company profile and research snapshot.
Company profile
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.